SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ImmunityBio converts from Immunomedics
An SI Board Since February 2023
Posts SubjectMarks Bans Symbol
1555 51 0 IBRX
Emcee:  TinfoilHat Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
85There's a new 8K file. Having problems posting link. Go to Edgarmannamal-3/20/2023
84Thanks to whomever cued me to listen to the Piper Sandler presentation again. GoTinfoilHat13/18/2023
83evaluate.commannamal-3/18/2023
82medpagetoday.commannamal-3/18/2023
81You forced me to listen to Addork again, man does he ever sound like a numbskullTinfoilHat-3/17/2023
80Re: "Vesanktiva already had a mid-cycle review, and the CEO/CMO were cited mannamal-3/17/2023
79Btw just read that Sorrento was awarded 125M due from NantPharma, a subsidiary oTinfoilHat-3/17/2023
78Voila, here is how they clarify the comparitor arm. Sounds shaky. **The externaTinfoilHat-3/17/2023
77Not sure I agree with your inference. SRP 9001 is a drug for a rare disease tesTinfoilHat-3/17/2023
76Thanks, took a position yesterday at 1.27....would like to add...but unsure on tcharles39-3/17/2023
75My take is why only 50M? Seems like a paltry sum for a company with multiple shoTinfoilHat-3/17/2023
74Srpt announced yesterday that the FDA will be having an Adcom committee meeting mannamal-3/17/2023
73Hey great write up.....what's your take on the recent offering....is their acharles39-3/17/2023
72If memory serves they had 100M at the end of Q4 then raised another 50 since theTinfoilHat23/17/2023
71From the 10Q: As a result of continuing anticipated operating cash outflows, wemannamal23/17/2023
70If total cash is $100M and you are saying they'll burn through $400M this yeThe Ox-3/17/2023
69Depends on the discount model you're using, assumptions of approvals and marTinfoilHat-3/17/2023
68I've followed this a bit but not too closely. It seems to me dilution for IThe Ox-3/16/2023
67I think this is a big deal, not just for Merck/Keytruda but the industry has beeTinfoilHat13/16/2023
66endpts.commannamal-3/16/2023
65Slow day, posing an idea here for those who enjoy speculating. Did some researTinfoilHat13/14/2023
64labusinessjournal.commannamal-3/13/2023
63Hey Ghetto, my understanding is the FDA wouldn't have approved the BLA if thTinfoilHat23/12/2023
62That was my conclusion too, about the lawsuit. There's just a lot of trash tghettogoulash13/11/2023
61I don't think a change to the trial's Estimated Completion Date is a facghettogoulash-3/11/2023
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News